• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者步态可变性测量的可重复性。

Reproducibility of gait variability measures in people with Alzheimer's disease.

机构信息

School of Allied Health, Faculty of Health Sciences, La Trobe University, Melbourne, Australia.

出版信息

Gait Posture. 2013 Jul;38(3):507-10. doi: 10.1016/j.gaitpost.2013.01.021. Epub 2013 Feb 26.

DOI:10.1016/j.gaitpost.2013.01.021
PMID:23485356
Abstract

Gait variability may be especially important to measure in people with Alzheimer's disease (AD) as it is related to risk of falling and may reflect the cognitive demand of walking. Its usefulness as an outcome measure in people with AD is currently limited by the lack of published evaluation of its reproducibility. Therefore measures of temporal and spatial gait variability were recorded using an instrumented mat on two occasions, one week apart in 16 community-dwelling people with mild to moderate probable AD. Data were combined in three ways for analysis: all available strides; all available strides from walks with mean velocity within 10cm/s of each other; and the first 12 strides from the second method. Measures of velocity, stride length and cadence variability were all found to have good reliability using an average of 64 strides from velocity-matched walks (ICC3,1 0.77-0.90) however only stride length variability reached acceptable reliability for a clinical test (ICC3,1 0.9). Estimates of the number of strides required to reach an ICC of 0.9 for velocity, cadence and stride width variability were between 169 and 212. Poor to moderate reliability of gait variability measures was obtained using 12 strides. Minimal detectable change values, calculated to reflect absolute agreement, appear to be feasible and may assist with evaluation of interventions to improve gait. Further research should examine the effects on reproducibility of gait variability measures, of systematic cueing aimed at producing consistent, optimal walking in larger groups with a range of dementia type and severity.

摘要

步态变异性在阿尔茨海默病(AD)患者中可能特别重要,因为它与跌倒风险有关,并且可能反映出行走的认知需求。目前,由于缺乏对其可重复性的发表评估,因此它作为 AD 患者的结果测量的实用性受到限制。因此,在 16 名轻度至中度可能患有 AD 的社区居住者中,使用仪器垫在两次不同的时间(相隔一周)记录了时间和空间步态变异性的测量值。数据分析时将数据以三种方式组合:所有可用步;彼此之间平均速度相差 10cm/s 的所有可用步;以及第二种方法的前 12 步。使用平均 64 步速度匹配步行(ICC3,1 0.77-0.90),发现速度、步长和步频变异性的测量值均具有良好的可靠性,但是只有步长变异性达到了临床测试的可接受可靠性(ICC3,1 0.9)。达到 ICC 为 0.9 的速度、步频和步宽变异性所需的步数估计值在 169 到 212 之间。使用 12 步获得了步态变异性测量值的较差到中等可靠性。为反映绝对一致性而计算的最小可检测变化值似乎是可行的,并且可能有助于评估改善步态的干预措施。进一步的研究应该检查针对产生一致,最佳行走的系统提示对步态变异性测量的可重复性的影响,在具有不同痴呆类型和严重程度的更大人群中。

相似文献

1
Reproducibility of gait variability measures in people with Alzheimer's disease.阿尔茨海默病患者步态可变性测量的可重复性。
Gait Posture. 2013 Jul;38(3):507-10. doi: 10.1016/j.gaitpost.2013.01.021. Epub 2013 Feb 26.
2
Test-retest reliability of spatial and temporal gait parameters of people with Alzheimer's disease.阿尔茨海默病患者步态时空参数的重测信度
Gait Posture. 2008 Oct;28(3):392-6. doi: 10.1016/j.gaitpost.2008.01.007. Epub 2008 Mar 5.
3
Timing variability during gait initiation is increased in people with Alzheimer's disease compared to controls.与对照组相比,阿尔茨海默病患者在步态起始过程中的时间变异性增加。
Dement Geriatr Cogn Disord. 2008;26(3):277-83. doi: 10.1159/000160961. Epub 2008 Oct 8.
4
Gait and risk of falls associated with frontal cognitive functions at different stages of Alzheimer's disease.阿尔茨海默病不同阶段的步态和跌倒风险与额认知功能的关系。
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2012 Sep;19(5):644-56. doi: 10.1080/13825585.2012.661398. Epub 2012 Feb 23.
5
Gait variability in community dwelling adults with Alzheimer disease.社区居住的阿尔茨海默病成年人的步态变异性
Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):37-40. doi: 10.1097/01.wad.0000201849.75578.de.
6
A longitudinal study of measures of walking in people with Alzheimer's Disease.阿尔茨海默病患者行走能力的纵向研究。
Gait Posture. 2010 May;32(1):113-7. doi: 10.1016/j.gaitpost.2010.04.001. Epub 2010 May 5.
7
Is gait variability reliable in older adults and Parkinson's disease? Towards an optimal testing protocol.老年人和帕金森病患者的步态变异性是否可靠?迈向最佳测试方案。
Gait Posture. 2013 Apr;37(4):580-5. doi: 10.1016/j.gaitpost.2012.09.025. Epub 2012 Oct 25.
8
Number of strides required for reliable measurements of pace, rhythm and variability parameters of gait during normal and dual task walking in older individuals.在老年人正常和双重任务行走期间,测量步伐、节奏和变异性参数所需的步数。
Gait Posture. 2010 May;32(1):23-8. doi: 10.1016/j.gaitpost.2010.02.017. Epub 2010 Apr 2.
9
Effect of rhythmic auditory cueing on gait in people with Alzheimer disease. rhythmic auditory cueing 对阿尔茨海默病患者步态的影响。
Arch Phys Med Rehabil. 2013 Apr;94(4):718-24. doi: 10.1016/j.apmr.2012.11.009. Epub 2012 Nov 13.
10
Test-retest reliability and minimal detectable change scores for the timed "up & go" test, the six-minute walk test, and gait speed in people with Alzheimer disease.阿尔茨海默病患者定时“起立行走”测试、六分钟步行测试及步速的重测信度和最小可检测变化值
Phys Ther. 2009 Jun;89(6):569-79. doi: 10.2522/ptj.20080258. Epub 2009 Apr 23.

引用本文的文献

1
Age-related and dual task-induced gait alterations and asymmetry: optimizing the Semmelweis Study gait assessment protocol.年龄相关及双重任务诱发的步态改变与不对称性:优化塞麦尔维斯研究步态评估方案
Geroscience. 2025 Jun 6. doi: 10.1007/s11357-025-01722-6.
2
Preventing spontaneous cerebral microhemorrhages in aging mice: a novel approach targeting cellular senescence with ABT263/navitoclax.预防衰老小鼠自发性脑微出血:一种靶向细胞衰老的新型方法,使用 ABT263/navitoclax。
Geroscience. 2024 Feb;46(1):21-37. doi: 10.1007/s11357-023-01024-9. Epub 2023 Dec 4.
3
The association between cognitive impairment, gait speed, and Walk ratio.
认知障碍、步速与步行比率之间的关联。
Front Aging Neurosci. 2023 May 18;15:1092990. doi: 10.3389/fnagi.2023.1092990. eCollection 2023.
4
Gait Variability to Phenotype Common Orthopedic Gait Impairments Using Wearable Sensors.使用可穿戴传感器对常见骨科步态障碍进行步态变异性与表型分析。
Sensors (Basel). 2022 Nov 29;22(23):9301. doi: 10.3390/s22239301.
5
Early manifestation of gait alterations in the Tg2576 mouse model of Alzheimer's disease.阿尔茨海默病 Tg2576 小鼠模型中步态改变的早期表现。
Geroscience. 2021 Aug;43(4):1947-1957. doi: 10.1007/s11357-021-00401-6. Epub 2021 Jun 23.
6
Increases in hypertension-induced cerebral microhemorrhages exacerbate gait dysfunction in a mouse model of Alzheimer's disease.高血压引起的脑微出血增加会加重阿尔茨海默病小鼠模型的步态功能障碍。
Geroscience. 2020 Dec;42(6):1685-1698. doi: 10.1007/s11357-020-00256-3. Epub 2020 Aug 25.
7
Home-Based Gait Training Using Rhythmic Auditory Cues in Alzheimer's Disease: Feasibility and Outcomes.基于家庭的节奏性听觉提示步态训练在阿尔茨海默病中的应用:可行性与结果
Front Med (Lausanne). 2020 Jan 31;6:335. doi: 10.3389/fmed.2019.00335. eCollection 2019.
8
Recommended motor assessments based on psychometric properties in individuals with dementia: a systematic review.基于心理测量特性的痴呆症患者运动评估推荐:一项系统综述。
Eur Rev Aging Phys Act. 2019 Nov 3;16:20. doi: 10.1186/s11556-019-0228-z. eCollection 2019.
9
A Home-Based, Music-Cued Movement Program Is Feasible and May Improve Gait in Progressive Supranuclear Palsy.一项基于家庭的音乐引导运动计划是可行的,并且可能改善进行性核上性麻痹患者的步态。
Front Neurol. 2019 Feb 19;10:116. doi: 10.3389/fneur.2019.00116. eCollection 2019.
10
Less Is More - Estimation of the Number of Strides Required to Assess Gait Variability in Spatially Confined Settings.少即是多——在空间受限环境中评估步态变异性所需步数的估计
Front Aging Neurosci. 2019 Jan 21;10:435. doi: 10.3389/fnagi.2018.00435. eCollection 2018.